Europeiska unionen -
svenska -
EMA (European Medicines Agency)
vocabria
viiv healthcare b.v. - cabotegavir sodium, cabotegravir - hiv-infektioner - antivirala medel för systemisk användning - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna.
Europeiska unionen -
svenska -
EMA (European Medicines Agency)
apretude
viiv healthcare b.v. - cabotegravir - hiv-infektioner - antivirala medel för systemisk användning - apretude is indicated in combination with safer sex practices for pre-exposure prophylaxis (prep) to reduce the risk of sexually acquired hiv-1 infection in high-risk adults and adolescents, weighing at least 35 kg (see sections 4. 2, 4. 4 och 5.
Europeiska unionen -
svenska -
EMA (European Medicines Agency)
ipique
rotterdam biologics b.v. - bevacizumab - wet macular degeneration - ögonsjukdomar - treatment of neovascular (wet) age-related macular degeneration (amd).